Status:
UNKNOWN
Protective Effect of N-acetylcysteine on Early Outcomes of Deceased Renal Transplant
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Renal Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigate the therapeutic effects of the antioxidant N-acetylcysteine on early outcomes of deceased renal transplant patients.
Detailed Description
Investigate the therapeutic effects of 600 mg bid po of N-acetylcysteine on early outcomes of deceased renal transplant patients regarding oxidative stress and renal function. Adult primary graft rec...
Eligibility Criteria
Inclusion
- primary deceased renal transplant recipients
- adult (\>18 yo)
Exclusion
- unable to drink N-acetylcysteine during the first 7 PO
- participation in other study
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00994305
Start Date
April 1 2005
End Date
December 1 2009
Last Update
October 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo General Hospital Kidney Transplant Unit
São Paulo, São Paulo, Brazil